Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.46 USD | +2.10% | +4.29% | -0.68% |
13/03 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SPERO THERAPEUTICS, INC. | Bio Therapeutic Drugs | +2.10% | +4.29% | -0.68% | -17.51% | -87.90% | 78.68M |
Technical Rankings Surperformance
- Stock Market
- Equities
- SPRO Stock
- Charts Spero Therapeutics, Inc.
- Comparison Chart